This podcast segment features the Q&A from IQVIA’s May 25, 2022 webinar hosted IQVIA experts Raina Olexa, Senior Principal Scientist Regulatory Science and Strategy, and Mui Van Zandt, VP and GM Real World Data and Technology, as they answer questions… Continue Reading
As my writing for the AdverseEvents Blog can attest, I’m in favor of data transparency. In my view, no organization should have monopolistic control over important information that limits the ability for healthcare decision makers to perform unbiased, objective comparative… Continue Reading
The challenges A key hurdle facing the entire pharmaceutical industry is non-adherence by patients to medication. This problem is only likely to be surmounted if patients believe that taking medication will lead to immediate benefits through reduction of symptoms, improvement… Continue Reading
